Title registration for a review proposal: 12-step programmes for reducing abuse of illicit drugs
|
|
|
- Loren Fox
- 10 years ago
- Views:
Transcription
1 Title registration for a review proposal: 12-step programmes for reducing abuse of illicit drugs Submitted to the Coordinating Group of: Social Welfare TITLE OF THE REVIEW 12-step programmes for reducing abuse of illicit drugs BACKGROUND Briefly describe and define the problem United Nations Office on Drugs and Crime estimate that between 18 and 38 million people worldwide are problematic drug users, and the majority of these use illicit drugs (UNODC, 2009). Drug abuse is strongly correlated to a range of social problems; including crime, prostitution, homelessness etc. and the social costs of these problems are high in many countries. Therefore, there is a strong political interest in the effectiveness of different treatments for abusers of illicit drugs. 12-step programmes for reducing drug abuse is a well-known and widespread treatment in many countries. Originally, the 12-step program emerged as self-help groups for alcoholics (Alcoholics Anonymous), but the idea has dispersed to a wide range of addiction types. The idea behind the 12-step program is that the addicts work their way into recovery by going through Twelve Steps starting with the recognition of being an addict and ending with the capability of helping others out of their addiction (Narcotics Anonymous 2008). The twelve steps are accompanied by twelve traditions providing guidelines for the self-help groups (ibid). A central element in the 12-step self-help groups is that participation is voluntary and that the 12 steps are carried by the addicts themselves, not by professionals. The most widespread 12-step program for reducing drug abuse is Narcotics Anonymous (NA), which emerged from Alcoholics Anonymous in the late 1940s. 1 The Campbell Collaboration
2 Today NA has more than 50,000 weekly meetings in 130 countries (Narcotics Anonymous 2007). NA is for all drug addicts, regardless of the particular drug or combination of drugs used. Other 12-step groups restrict themselves to specific type of drug abuse, such as Cocaine Anonymous, Pills Anonymous and Marijuana Anonymous ( The 12-step concept is also used in programmes provided by professionals (12-step facilitation programmes). These can take place either in an individual or group setting, but use the 12-step concepts in the treatment. An example is the Twelve Step Facilitation Outpatient Program, which is a manualised program for clients with substance abuse disorders (alcohol or narcotics). In this program, the addict participates in one-to-one individual facilitation sessions, as well as in group treatments with the primary goal being to facilitate active involvement in e.g. Narcotics Anonymous (Nowinski, 2006). Despite the extensive use of 12-step programmes, no systematic review exists on the effectiveness of the interventions in relation to reducing drug abuse and socially related outcomes. The objective of this review is to evaluate current evidence about the effects of 12-step programmes for drug addicts. Briefly describe and define the population The population will be persons, who abuse different illicit drugs of all kinds. We impose no age restrictions as 12-step programmes are used for all age-groups (although mainly for adults). The population included in this review can be abusers of both illicit drugs and alcohol; however participants with an exclusive alcohol problem will be excluded. Exclusion criteria will be: Drug treatment in prisons or other types of locked institutions Compulsory treatment e.g. court-mandated sentences Briefly describe and define the intervention Interventions that will be included in this review are Twelve Step programmes (like Narcotics Anonymous) and other Twelve Step Facilitation programmes, which use the twelve steps in the treatment. Included interventions are carried out in self-help groups or by professionals in an individual or group setting. Furthermore, the Twelve Step Facilitation can take place as inpatient (e.g. rehab centres with overnight stays) as well as outpatient (treatment without overnight stays) settings, whereas self-help groups will always be based in the local community. Twelve step interventions using a manual where the twelve 2 The Campbell Collaboration
3 steps are defined will be included. The Twelve Step Facilitation programme can be combined with other treatment elements, but the 12-step element of the programme should be well-defined and should be the main intervention/treatment. The duration of treatment in Twelve Step programmes can be very long. Membership of e.g. Narcotics Anonymous is typically for a very long periods of time (according to NA, members have on average been clean 9.1 years (NA, 2007)). On the other hand, programmes run by professionals will typically have durations of 4-8 weeks. Because of this difference, inclusion in the intervention in this review is based on enrolment into the treatment. Comparison Comparison conditions will include no intervention, waitlist controls and other types of interventions (such as other types of psychosocial or medical treatment, e.g. methadone). In most cases, the comparison group will receive some treatment. Outcomes: What are the intended effects of the intervention? Primary Abstinence or reduction of drug abuse and improvement of psychosocial functioning are the primary outcomes of interest. Reduction of Drug abuse: Measured through biochemically tests (e.g. urine screen measures for drug use) Measured through self-reported estimates on drug use Measured through psychometric scales (e.g. Addiction Severity Index (ASI, originally version developed by McLellan et al. 1980) Psychosocial functioning: Measured through psychometric scales (e.g. Diagnostic and Statistical Manual of Mental Disorders (DSM, originally version developed by American Psychiatric Association in 1952, the last version DSM-IV published in 1994 (American Psychiatric Association 1994, 2000) or broader quality of life measures (e.g. as described by Kind 1994) Measured through levels of involvement in education and work (self-reported or reported by authorities, files, registers) Measured through crime rates (self-reported or reported by authorities, files, registers) Measured through frequency of risk behaviour, e.g. injecting drugs, prostitution (self-reported or reported by authorities, files, registers) Secondary 3 The Campbell Collaboration
4 Retention Adverse effects Costs Outcomes will be considered in the following intervals: Short term effects (0-6 months after enrolment into treatment Medium term effect (6-12 months) Long term effects (more than 12 months) OBJECTIVES The objective of this review is to evaluate current evidence about the effects of 12- step programmes for drug addicts. METHODOLOGY What types of studies designs are to be included and excluded? Randomized controlled trials (RCTs), cluster randomised trials and quasi randomised trials will be included in this review. Furthermore, quasi experimental designs (QEDs) will be included. By QEDs we refer to quantitative effect study designs, where a counterfactual can be established (e.g. before and after studies with prospective parallel groups and baseline controls). The rationale for including quasi experimental designs in this review is as follows: Quasi-experimental studies can inform the relationship between 12 steps programmes and substance abuse treatment outcomes. In particular, quasiexperimental studies can shed light on whether findings are externally valid and, where appropriate, such studies may be combined with randomized controlled trials thereby increasing the number of included studies and improving our ability to conduct relevant moderator analyses. For duration of follow up see outcomes section. Control groups will include no intervention, waitlist controls, and other interventions. 4 The Campbell Collaboration
5 REFERENCES American Psychiatric Association (1994): Diagnostic and statistical manual of mental disorders, DSM-IV. American Psychiatric Association (pub.), Arlington. American Psychiatric Association (2000): Diagnostic and statistical manual of mental disorders, Text revision, DSM-IV-TR. American Psychiatric Association (pub.), Arlington. Kind P. (1994): Issues in the design and construction of a quality of life measure. In Baldwin, S., Godfrey, C. & Propper, C. Quality of life. Routledge, London. McLellan A. T., Luborsky L., Woody G. E., O Brian C. P. (1980): An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disorders 168, 1: Narcotics Anonymous (2007): Information about NA (PDF). Van Nuys, CA: Narcotics Anonymous World Services Inc. Narcotics Anonymous (2008): Narcotics Anonymous, Basic Text, Sixth Edition (PDF). Van Nuys, CA: Narcotics Anonymous World Services Inc. Nowinski, Joseph (2006): Twelve Step Facilitation Outpatient Program, The Project Match Twelve Step Treatment Protocol. Hazelden Information & Educational Services. UNODC (2009): UN Drug report United Nations Publications, New York. SOURCES OF SUPPORT Internal funding: SFI Campbell External funding: DECLARATIONS OF INTEREST None known 5 The Campbell Collaboration
6 REQUEST SUPPORT Do you need support in any of these areas (methodology, statistics, systematic searches, field expertise, review manager etc?) AUTHOR(S) REVIEW TEAM Include the complete name and address of reviewer(s) (can be changed later).this is the review team -- list the full names, affiliation and contact details of author s to be cited on the final publication. Lead reviewer: The lead author is the person who develops and co-ordinates the review team, discusses and assigns roles for individual members of the review team, liaises with the editorial base and takes responsibility for the on-going updates of the review Name: Mette Deding Title: Director of research Affiliation: SFI Campbell Address: Herluf Trolles Gade 11 City, State, Province or County: Copenhagen K Postal Code: DK Country: Denmark Phone: Mobile: [email protected] Co-author: Name: Lars Brännström Title: PhD in Sociology Affiliation: Swedish National Board of Health and Welfare [email protected] Co-author: Name: Trine Filges Title: PhD in Economics Affiliation: SFI Campbell [email protected] Co-author: Name: Anne-Marie Klint Jørgensen Title: Information specialist Affiliation: SFI Campbell [email protected] Co-author: Name: Margareta Järvinen Title: Professor of Sociology Affiliation: The Danish National Centre for Social Research and Department of Sociology, University of Copenhagen [email protected] 6 The Campbell Collaboration
7 ROLES AND RESPONSIBILITIES Please give brief description of content and methodological expertise within the review team. The recommended optimal review team composition includes at least one person on the review team who has content expertise, at least one person who has methodological expertise and at least one person who has statistical expertise. It is also recommended to have one person with information retrieval expertise. Who is responsible for the below areas? Please list their names: Content: Mette Deding & Margareta Järvinen Systematic review methods: Mette Deding & Lars Brännström Statistical analysis: Trine Filges & Lars Brännström Information retrieval: Anne-Marie Klint Jørgensen PRELIMINARY TIMEFRAME Approximate date for submission of Draft Protocol (please note this should be no longer than six months after title approval. If the protocol is not submitted by then, the review area may be opened up for other reviewers): Title registration approval date: Draft protocol submission date: November The Campbell Collaboration
Brief Strategic Family Therapy (BSFT) for young people in treatment for illicit nonopioid
Title registration for a review proposal: Brief Strategic Family Therapy (BSFT) for young people in treatment for illicit nonopioid drug use Maia Lindstrøm, Pernille Skovbo Rasmussen, Krystyna Kowalski,
Family Behavior Therapy (FBT) for young people in treatment for illicit non-opioid
Title registration for a review proposal: Family Behavior Therapy (FBT) for young people in treatment for illicit non-opioid drug use Maia Lindstrøm, Pernille Skovbo Rasmussen, Krystyna Kowalski, Trine
Multidimensional Family Therapy (MDFT) for young people in treatment for illicit
Title registration for a review proposal: Multidimensional Family Therapy (MDFT) for young people in treatment for illicit non-opioid drug use Pernille Skovbo Rasmussen, Maia Lindstrøm, Krystyna Kowalski,
The Effect of Family Background on the Risk of Homelessness in a Cohort of Danish Adolescents
The Effect of Family Background on the Risk of Homelessness in a Cohort of Danish Adolescents Lars Benjaminsen The Danish National Center for Social Research Problem What is the family background of young
The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.
New Jersey Substance Abuse Monitoring System The NJSAMS Report May 2011 Admissions to Substance Abuse Treatment in New Jersey eroin is a semi-synthetic opioid drug derived from morphine. It has a high
Q6: Should non-specialist health care providers refer alcohol dependent patients and their family members to mutual help groups such as AA?
Q6: Should non-specialist health care providers refer alcohol dependent patients and their family members to mutual help groups such as AA? Background Self help groups such as Alcoholics Anonymous (AA)
Effectiveness of Treatment The Evidence
Effectiveness of Treatment The Evidence The treatment programme at Castle Craig is based on the 12 Step abstinence model. This document describes the evidence for residential and 12 Step treatment programmes.
Medical Prescription of Heroin the Dutch trial in the context of a developing treatment system
Medical Prescription of Heroin the Dutch trial in the context of a developing treatment system Wim van den Brink, MD PhD Vincent M Hendriks, PhD Peter Blanken, MA Jan M van Ree, MSc PhD Central Committee
A briefing on the evidence-based drug and alcohol treatment guidance recommendations on mutual aid
A briefing on the evidence-based drug and alcohol treatment guidance recommendations on mutual aid A briefing on the evidence-based drug and alcohol treatment guidance recommendations on mutual aid About
Phone: 020 79115334 Email: [email protected]
Title Registration for a Systematic Review: Post-basic technical and vocational education and training (TVET) interventions to improve employability and employment of TVET graduates in low- and middle-income
YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT
YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT Siobhan A. Morse, MHSA, CRC, CAI, MAC Director of Fidelity and Research Foundations Recovery Network YOUNG
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment Background Studies show that more than 50% of patients who have been diagnosed with substance abuse
REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003
REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY The New York Community Trust April 2003 1 I. INTRODUCTION Substance Abuse is defined as the excessive use of addictive substances, especially narcotic drugs,
Current Models of Recovery Support Services: Where We Have Data and Where We Don t
Current Models of Recovery Support Services: Where We Have Data and Where We Don t Richard Rawson, Ph.D. Integrated Substance Abuse Programs University of California, Los Angeles 1. Define recovery Talk
SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE
SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE By: Christine Kim Cal State University, Long Beach May 2014 INTRODUCTION Substance use among
Anthony Petrosino, Sarah Guckenburg, Trevor Fronius
Title Registration for a Systematic Review: Policing Schools Strategies to Reduce Crime, Increase Perceptions of Safety, and Improve Learning Outcomes in Primary and Secondary Schools Anthony Petrosino,
Predictors of Substance Abuse Treatment Engagement among Rural Appalachian Prescription Drug Users
Predictors of Substance Abuse Treatment Engagement among Rural Appalachian Prescription Drug Users Jennifer R. Havens, PhD, MPH Carrie B. Oser, PhD Carl G. Leukefeld, PhD Study Objective The objective
Observational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction STUDY PROTOCOL
Observational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction Purpose and Objectives STUDY PROTOCOL This research is an investigator-sponsored observational
Effects of Distance to Treatment and Treatment Type on Alcoholics Anonymous Attendance and Subsequent Alcohol Consumption. Presenter Disclosure
Effects of Distance to Treatment and Treatment Type on Alcoholics Anonymous Attendance and Subsequent Alcohol Consumption Jamie L. Heisey, MA Katherine J. Karriker-Jaffe, PhD Jane Witbrodt, PhD Lee Ann
Family interventions for drug. Family interventions for drug. best practice?
Family interventions for drug Family interventions for drug and alcohol misuse: Is there a best practice? Prof Alex Copello Consultant Clinical Psychologist Addiction Services Birmingham and Solihull Mental
Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
Performance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
African American Women and Substance Abuse: Current Findings
African American Women and Substance Abuse: Current Findings Based on the work of Amelia Roberts, Ph.D. Assistant Professor, UNC School of Social Work and Iris Carleton-LeNay, Ph.D. Professor, UNC School
Root Cause Analysis of Addiction: An Ongoing Study ERIC J. KOCIAN, PH.D. SAINT VINCENT COLLEGE JULY 21, 2015
Root Cause Analysis of Addiction: An Ongoing Study ERIC J. KOCIAN, PH.D. SAINT VINCENT COLLEGE JULY 21, 2015 Genesis: How This Study Began Heroin: Pure Evil and the toll it takes on the individual, the
DRAFT Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study Final Report UPDATED
DRAFT Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study Final Report UPDATED Prepared for: The DWI Addiction Treatment Programs (ATP) Metropolitan Detention Center
Special Populations in Alcoholics Anonymous. J. Scott Tonigan, Ph.D., Gerard J. Connors, Ph.D., and William R. Miller, Ph.D.
Special Populations in Alcoholics Anonymous J. Scott Tonigan, Ph.D., Gerard J. Connors, Ph.D., and William R. Miller, Ph.D. The vast majority of Alcoholics Anonymous (AA) members in the United States are
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American
Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling
Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling Midwest Conference on Problem Gambling and Substance Abuse 2006 Problem Gambling and Co-occurrence: Improving Practice and Managing
Individual Therapies Group Therapies Family Interventions Structural Interventions Contingency Management Housing Interventions Rehabilitation
1980s Early studies focused on providing integrated treatment for individuals who have dual diagnosis (adding SA counseling to community MH treatment) Early studies also showed that clients did not readily
An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines Guideline Evaluation and Treatment Planning Discharge Planning Admission Criteria Continued Stay Criteria Discharge
The concept of National guidelines for treatment of alcohol and drug problems/ dependence in Sweden 2007
The concept of National guidelines for treatment of alcohol and drug problems/ dependence in Sweden 2007 Ulf Malmström coordinator, PhD National Board of Health and Welfare Cyprus May 2009 Why establish
Behavioral Health Barometer. Oklahoma, 2014
Behavioral Health Barometer Oklahoma, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
Behavioral Health Barometer. Mississippi, 2014
Behavioral Health Barometer Mississippi, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
Treatment/Screening Resources
Inclusion of resources on this list does not denote endorsement of these resources by Jefferson County Public Health. The resources included here have been determined to meet a general standard for credibility/validity
Behavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Effective January 1, 2011 Revised and approved on 8/19/2010 The Office of Medical Policy and Technological Assessment (OMPTA) has developed policies that serve
American Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Parity in Benefit Coverage: A Joint Statement by ASAM and AMBHA The American Managed Behavioral Healthcare Association (AMBHA) and the
Appendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines
Appendix D Behavioral Health Partnership Adolescent/Adult Substance Abuse Guidelines Handbook for Providers 92 ASAM CRITERIA The CT BHP utilizes the ASAM PPC-2R criteria for rendering decisions regarding
Office-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
AA - APA Webinar 5/2014 1
THE PSYCHOLOGY OF AA AND NA AND THEIR ROLE IN CLINICAL CARE Marc Galanter, M.D. Professor of Psychiatry and Director Division of Alcoholism and Drug Abuse NYU School of Medicine Dr. Galanter has no conflicts
TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
Resources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug
The Changing Face of Opioid Addiction:
9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept
PERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment
UPDATED 31.5.2016 PERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment Psychosocial interventions are structured psychological or social interventions used to address substance-related
with substance use disorders
Assessing the Evidence Base Series Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence Sharon Reif, Ph.D. Preethy George, Ph.D. Lisa Braude, Ph.D. Richard H. Dougherty,
A copy can be downloaded for personal non-commercial research or study, without prior permission or charge
McKeganey, N. (2010) Rediscovering recovery in drug and alcohol treatment services. In: Brown, J. and Campbell, E.A. (eds.) Cambridge Handbook of Forensic Psychology. University of Cambridge. ISBN 9780521701815
SUBSTANCE ABUSE OUTPATIENT SERVICES
SUBSTANCE ABUSE OUTPATIENT SERVICES A. DEFINITION: Substance Abuse Outpatient is the provision of medical or other treatment and/or counseling to address substance abuse problems (i.e., alcohol and/or
PEER LEARNING COURT PROGRAM
PEER LEARNING COURT PROGRAM MIAMI-DADE COUNTY DEPENDENCY DRUG COURT LEAD AGENCY Miami-Dade County Dependency Drug Court LOCATION Miami, Florida FIRST DATE OF OPERATION August 2004 CAPACITY Adults: 75 NUMBER
Behavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett
ARTICLE 4.4. ADDICTION TREATMENT SERVICES PROVIDER CERTIFICATION
ARTICLE 4.4. ADDICTION TREATMENT SERVICES PROVIDER CERTIFICATION Rule 1. Definitions 440 IAC 4.4-1-1 Definitions Affected: IC 12-7-2-11; IC 12-7-2-73 Sec. 1. The following definitions apply throughout
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working
Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study for DWI Offenders
Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study for DWI Offenders Prepared for: The DWI Addiction Treatment Programs (ATP) Metropolitan Detention Center Prepared
Treatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
A Recovery Orientated System of Care for Ayrshire and Arran
A Recovery Orientated System of Care for Ayrshire and Arran 1. BACKGROUND 1.1 The national alcohol and drug strategies, Changing Scotland Relationship with alcohol and The Road to Recovery signalled a
James Madison University Department of Graduate Psychology PSYC 663-0001: Substance Abuse Counseling Sample Syllabus
James Madison University Department of Graduate Psychology PSYC 663-0001: Substance Abuse Counseling Sample Syllabus Inclement Weather: The University may close or limit its services based on inclement
People affected by drug and alcohol misuse
Fact Sheet Local Account of Adult Social Care 2013-14 What we spent in 2013-14 M s experience of rehab and aftercare Drug & Alcohol Expenditures 2% 18% 35% Community drug treatment 35% Specialist clinical
LIMPOPO REPUBLIC OF SOUTH AFRICA SUBSTANCE ABUSE POLICY
LIMPOPO PROVINCIAL GOVERNMENT REPUBLIC OF SOUTH AFRICA SUBSTANCE ABUSE POLICY TABLE OF CONTENTS PAGES Glossary 3 1. Preamble 4 2. Purpose 4 3. Legal Framework 4 4. Scope of application 5 5. Policy principles
Co-Occurring Disorders
Presented by Pamela Messore LICSW, LCDP Co-Occurring Disorder - formerly Dual Diagnosis - was once a challenge to providers. Historically, clients were treated in separate modalities - even separate agencies.
Co occuring Antisocial Personality Disorder and Substance Use Disorder: Treatment Interventions Joleen M. Haase
Co occuring Antisocial Personality Disorder and Substance Use Disorder: Treatment Interventions Joleen M. Haase Abstract: Substance abuse is highly prevalent among individuals with a personality disorder
Overview of the Breaking Free research and evaluation programme. Based on the MRC framework for developing and evaluating complex interventions
Overview of the Breaking Free research and evaluation programme Based on the MRC framework for developing and evaluating complex interventions June 2015 1 Overview of the Breaking Free research and evaluation
Factors predicting attrition from prison-based intensive psychosocial drug treatment
Factors predicting attrition from prison-based intensive psychosocial drug treatment Eli Grant, Sean Grant, Paul Montgomery To start a Campbell review, a title must be registered and approved by the appropriate
12-step Programs for Reducing Illicit Drug Use: Protocol for a Systematic Review PROTOCOL
12-step Programs for Reducing Illicit Drug Use: Protocol for a Systematic Review Mette Deding, Madina Saidj, Lars Brännström, Margaretha Järvinen, Anne-Marie Klint Jørgensen & Maja Kärrman Fredriksson
County of San Diego Health and Human Services Agency (HHSA) Mental Health Services Policies and Procedures MHS General Administration
MHS FINAL Subject: Referenc Specialty for Clients with Co-occurring CCR Title 9; Co-occurring Psychiatric and Substance Abuse Disorders Consensus Document No: 01-02-205 Formerly: 01-06-117 Page: 1 of 7
Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
GENERAL INSTRUCTIONS
This section provides definitions and general instructions for the Montana Substance Abuse Management System (SAMS). Subject areas include system overview, program requirements, system components and general
Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
TREATMENT OF ALCOHOL ABUSE
Danish Centre for Evaluation and Health Technology Assessment TREATMENT OF ALCOHOL ABUSE A health technology assessment - summary Anette Søgaard Nielsen 1, Ulrik Becker 1, Betina Højgaard 2, Anders Blædel
DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
HOW TO PREPARE FOR AN ADMINISTRATIVE REVIEW OR LICENSE APPEAL HEARING INVOLVING SUBSTANCE USE RELATED OFFENSES. Administrative Reviews
HOW TO PREPARE FOR AN ADMINISTRATIVE REVIEW OR LICENSE APPEAL HEARING INVOLVING SUBSTANCE USE RELATED OFFENSES Administrative Reviews You are eligible for an administrative review if you meet one of the
University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
